Literature DB >> 3627284

Local cerebral glucose utilization and local cerebral blood flow in conscious rats after administration of flunarizine.

T Beck, J Krieglstein.   

Abstract

The effects of the calcium entry blocker flunarizine on physiologic variables, local cerebral blood flow (LCBF) and local cerebral glucose utilization (LCGU) were investigated. LCBF and LCGU were determined in 37 anatomically discrete brain regions in lightly restrained, conscious rats, using the quantitative, autoradiographic 14C-iodoantipyrine and 14C-2-deoxyglucose techniques. While 5 mg/kg flunarizine given i.v. did not change any of the measured physiologic variables, flunarizine increased LCBF in nearly all gray matter structures compared with saline-treated controls. LCGU was not changed compared to controls. In control as well as in flunarizine-treated rats coupling between LCGU and LCBF was tight. The ratio of LCBF/LCGU was increased after treatment with flunarizine. The data suggest that under normal physiological conditions the calcium entry blocker flunarizine does not change neuronal activity, but exerts primarily a cerebral vasodilating action.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3627284     DOI: 10.1007/BF00166986

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  38 in total

1.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

2.  Correlation between regional cerebral blood flow and oxidative metabolism. In vivo studies in man.

Authors:  M E Raichle; R L Grubb; M H Gado; J O Eichling; M M Ter-Pogossian
Journal:  Arch Neurol       Date:  1976-08

3.  Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart.

Authors:  D R Ferry; H Glossmann; A J Kaumann
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

4.  Effect of the calcium antagonist, nimodipine, on cerebral blood flow and metabolism in the primate.

Authors:  A M Harper; L Craigen; S Kazda
Journal:  J Cereb Blood Flow Metab       Date:  1981       Impact factor: 6.200

5.  Measurement of free glucose turnover in brain.

Authors:  H E Savaki; L Davidsen; C Smith; L Sokoloff
Journal:  J Neurochem       Date:  1980-08       Impact factor: 5.372

6.  Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis).

Authors:  J McCulloch; P A Kelly; I Ford
Journal:  J Cereb Blood Flow Metab       Date:  1982-12       Impact factor: 6.200

7.  The effects of lesions in the rat hippocampus suggest the association of calcium channel blocker binding sites with specific neuronal population.

Authors:  R Cortes; P Supavilai; M Karobath; J M Palacios
Journal:  Neurosci Lett       Date:  1983-12-11       Impact factor: 3.046

8.  [Effects of (E)-1-[bis (4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl) piperazine dihydrochloride(flunarizine) on cerebral circulation].

Authors:  K Kubo; A Karasawa; K Yamada; M Nito; K Shuto; N Nakamizo
Journal:  Nihon Yakurigaku Zasshi       Date:  1982-05

9.  Selective abolition of Ca-dependent responses of smooth and cardiac muscles by flunarizine.

Authors:  K Nakayama; Y Kasuya
Journal:  Jpn J Pharmacol       Date:  1980-10

10.  Calcium antagonists affect calmodulin-dependent contractility of a skinned smooth muscle.

Authors:  H Metzger; H O Stern; G Pfitzer; J C Rüegg
Journal:  Arzneimittelforschung       Date:  1982
View more
  3 in total

1.  The effects of HA1077, a novel protein kinase inhibitor, on reductions of cerebral blood flow and glucose metabolism following acute and/or chronic bilateral carotid artery ligation in Wistar rats.

Authors:  M Tsuchiya; K Sako; Y Yonemasu; T Asano
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

2.  Facilitation of shuttle-box avoidance behaviour in mice treated with nifedipine in combination with amphetamine.

Authors:  J Vetulani; M Battaglia; C Castellano; M Sansone
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 3.  Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.